Luisa M Russell

发表

Quantitative Evaluation of the Enhanced Permeability and Retention (EPR) Effect.

Luisa M Russell, Charlene M Dawidczyk, Peter C Searson, 2017, Methods in molecular biology.

National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.

Piotr Grodzinski, Luisa M Russell, Christopher M Hartshorn, 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines.

Martin G Pomper, Jea Ho Park, Luisa M Russell, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Peptide‐based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges

Luisa M Russell, K. Hristova, P. Searson, 2017, Advanced drug delivery reviews.

Development and Application of a Novel Model System to Study “Active” and “Passive” Tumor Targeting

Luisa M Russell, B. Trock, M. Pomper, 2016, Molecular Cancer Therapeutics.

Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action

Luisa M Russell, P. Searson, L. Russell, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Nanomaterials innovation as an enabler for effective cancer interventions.

Luisa M Russell, P. Grodzinski, Christina H. Liu, 2020, Biomaterials.

Chemotherapeutic Drug Delivery and Quantitative Analysis of Proliferation, Apoptosis, and Migration in a Tissue-Engineered Three-Dimensional Microvessel Model of the Tumor Microenvironment.

Luisa M Russell, Andrew D. Wong, P. Searson, 2018, ACS biomaterials science & engineering.

State-ofthe-Art in Design Rules for Drug Delivery Platforms : Lessons from FDA-approved Nanomedicines

Luisa M Russell, M. Pomper, P. Searson, 2014 .

Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments

Peter C. Searson, Luisa M Russell, P. Searson, 2014, Front. Chem..

Tumor accumulation of liposomal doxorubicin in three murine models: Optimizing delivery efficiency.

Luisa M Russell, P. Searson, Charlene M. Dawidczyk, 2017, Nanomedicine : nanotechnology, biology, and medicine.

Electronic Cortisol Detection Using an Antibody-Embedded Polymer Coupled to a Field-Effect Transistor.

Jian Song, Hui Li, Luisa Russell, 2018, ACS applied materials & interfaces.

Recommendations for Benchmarking Preclinical Studies of Nanomedicines.

Luisa M Russell, P. Searson, Charlene M. Dawidczyk, 2015, Cancer research.

Perspective: Recommendations for benchmarking pre-clinical studies of nanomedicines

Luisa M Russell, Charlene M. Dawidczyk, L. Russell, 2015 .

Translational Nanodiagnostics for In Vivo Cancer Detection

Luisa M Russell, Pushpa Tandon, Christina H. Liu, 2018, Bioanalysis.

NCI Alliance for Nanotechnology in Cancer – from academic research to clinical interventions

Stephanie A. Morris, Luisa M Russell, P. Grodzinski, 2019, Biomedical Microdevices.